Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBAL vs Humira in Rheumatoid Arthritis
NCT02746380Phase 3Completed
- Sponsor
- LG Chem
- Start
- Apr 2016
- Primary completion
- Jul 2017
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by LG Chem. Started Apr 2016; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02746380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02746380.